Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases

Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases

Bibliographic Details
Main Authors: Jordi Remon, MD, María Castro-Henriques, Laura Esteller, Josep Vives
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:JTO Clinical and Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320301429

Internet

http://www.sciencedirect.com/science/article/pii/S2666364320301429

Similar Items